Elevation of plasma transforming growth factor β1 levels in stable nonatopic asthma

被引:22
作者
Joseph, J
Benedict, S
Badrinath, P
Wassef, S
Joseph, M
Abdulkhalik, S
Nicholls, MG
机构
[1] United Arab Emirates Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates
[2] Tawam Hosp, Al Ain, U Arab Emirates
[3] Al Ain Hosp, Al Ain, U Arab Emirates
关键词
D O I
10.1016/S1081-1206(10)61516-5
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Increased transforming growth factor beta1 (TGF-beta1) levels have been reported in bronchoalveolar lavage fluid and bronchial biopsy specimens from asthmatic patients. However, systemic TGF-beta1 levels have not been reported in asthma. Objective: To evaluate the levels of plasma TGF-beta1 in asthmatic patients and matched, healthy controls to determine the associations with atopic status, disease severity, and duration. Methods: Asthmatic patients and healthy controls were recruited prospectively from a university hospital outpatient department between January 2001 and May 2002. Plasma TGF-beta1 and serum IgE levels were estimated using established methods. Patients were classified as atopic or nonatopic based on the presence or absence of serum specific IgE directed to common allergens. Results: Of the 56 patients recruited for the study, 32 were atopic and 24 nonatopic. The median value of plasma TGF-beta1 was significantly higher in nonatopic asthmatic patients (2.5 ng/mL) compared with controls (1.5 ng/mL, P =.002) and atopic asthmatic patients (1.4 ng/mL, P =.008). The median absolute neutrophil count in the nonatopic asthmatic patients (4.0 x 10(9)/L) was significantly higher compared with atopic asthmatic patients (3.0 x 10(9)/L) and healthy controls (3.5 x 10(9)/L) (P = .01 and P = .04). There was no significant correlation between the duration or severity of asthma and plasma TGF-beta1 levels. The distribution of moderate-persistent asthma cases was similar in atopic and nonatopic groups. Conclusion: Compared with atopic asthmatic patients and healthy controls, patients with nonatopic asthma have elevated plasma TGF-beta1 levels and leukocytosis. These data suggest that nonatopic asthmatic patients exhibit an altered inflammatory response, perhaps to a respiratory infection.
引用
收藏
页码:472 / 476
页数:5
相关论文
共 35 条
[1]   Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma [J].
Amin, K ;
Lúdvíksdóttir, D ;
Janson, C ;
Nettelbladt, O ;
Björnsson, E ;
Roomans, GM ;
Boman, G ;
Sevéus, L ;
Venge, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (06) :2295-2301
[2]   TRANSFORMING GROWTH-FACTOR-BETA AS A PREDICTOR OF LIVER AND LUNG FIBROSIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED BREAST-CANCER [J].
ANSCHER, MS ;
PETERS, WP ;
REISENBICHLER, H ;
PETROS, WP ;
JIRTLE, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1592-1598
[3]   Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation [J].
Asai, O ;
Longo, DL ;
Tian, ZG ;
Hornung, RL ;
Taub, DD ;
Ruscetti, FW ;
Murphy, WJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (09) :1835-1842
[4]   Cytokine modulators as novel therapies for airway disease [J].
Barnes, PJ .
EUROPEAN RESPIRATORY JOURNAL, 2001, 18 :67S-77S
[5]   TRANSFORMING GROWTH-FACTOR-BETA AS A VIRULENCE MECHANISM FOR LEISHMANIA-BRAZILIENSIS [J].
BARRAL, A ;
BARRALNETTO, M ;
YONG, EC ;
BROWNELL, CE ;
TWARDZIK, DR ;
REED, SG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3442-3446
[6]   TRANSFORMING GROWTH-FACTOR-BETA IN LEISHMANIAL INFECTION - A PARASITE ESCAPE MECHANISM [J].
BARRALNETTO, M ;
BARRAL, A ;
BROWNELL, CE ;
SKEIKY, YAW ;
ELLINGSWORTH, LR ;
TWARDZIK, DR ;
REED, SG .
SCIENCE, 1992, 257 (5069) :545-548
[7]   Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema:: ISAAC [J].
Beasley, R ;
Keil, U ;
von Mutius, E ;
Pearce, N ;
Aït-Khaled, N ;
Anabwani, G ;
Anderson, HR ;
Asher, MI ;
Björkstéin, B ;
Burr, ML ;
Clayton, TO ;
Crane, J ;
Ellwood, P ;
Lai, CKW ;
Mallol, J ;
Martinez, FD ;
Mitchell, EA ;
Montefort, S ;
Robertson, CF ;
Shah, JR ;
Sibbald, B ;
Stewart, AW ;
Strachan, DP ;
Weiland, SK ;
Williams, HC .
LANCET, 1998, 351 (9111) :1225-1232
[8]   TGF-β1:: immunosuppressant and viability factor for T lymphocytes [J].
Cerwenka, A ;
Swain, SL .
MICROBES AND INFECTION, 1999, 1 (15) :1291-1296
[9]   TGF-β:: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression [J].
Chen, WJ ;
Wahl, SM .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (02) :85-89
[10]  
Chu HW, 2000, J ALLERGY CLIN IMMUN, V106, P1115